Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: therapeutic effects by cilostazol and potentiation by dipyridamole
- 1 May 2004
- journal article
- research article
- Published by Taylor & Francis Ltd in Platelets
- Vol. 15 (3), 167-172
- https://doi.org/10.1080/09537100410001682779
Abstract
We evaluated the plasma concentrations of platelet activation markers, microparticles and soluble adhesion molecules in patients with arteriosclerosis obliterans (ASO) and compared the beneficial effects of cilostazol alone and combination therapy of cilostazol and dipyridamole in these patients. There was a significant elevation of CD62P, CD63, PAC-1, annexin V, platelet-derived microparticles (PDMPs), sP-selectin, sE-selectin, sICAM-1 and sVCAM-1 in the ASO patients compared with the controls. Platelet aggregation was decreased by 2 weeks of cilostazol monotherapy in the ASO patients. Adding dipyridamole to the cilostazol therapy for 2 weeks further reduced platelet aggregation. While treatment with cilostazol alone reduced levels of CD62P, CD63, PAC-1, annexin V, PDMP, and sP-selectin, the combination therapy reduced these parameters further. While sE-selectin and cell adhesion molecules did not change significantly after 2 weeks of combination therapy, they exhibited a remarkable decrease after 16 weeks of combination treatment. These findings suggest that platelets are activated in ASO patients, and cilostazol is effective to reduce platelet activation. Furthermore, dipyridamole may potentiate the beneficial effect of cilostazol in ASO patients. Combination use of both drugs may help to prevent the onset of cardiovascular complications in patients with ASO by activated platelets and PDMP.Keywords
This publication has 27 references indexed in Scilit:
- Cilostazol as a Unique Antithrombotic AgentCurrent Pharmaceutical Design, 2003
- Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery diseaseEuropean Journal of Clinical Investigation, 1996
- The IntimaCirculation Research, 1995
- The Response-to-Retention Hypothesis of Early AtherogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.JCI Insight, 1991
- Assembly of the Platelet Prothrombinase Complex Is Linked to Vesiculation of the Platelet Plasma MembraneOnline Journal of Public Health Informatics, 1989
- The association of in vitro arachidonic acid responsiveness and plasma thromboxane levels with early platelet deposition on the luminal surface of small-diameter graftsJournal of Vascular Surgery, 1988
- Effect of Prolonged Intra-arterial Prostaglandin E1 Infusion on Canine Arterial Graft PatencyArchives of Surgery, 1986
- The Pathogenesis of Atherosclerosis — An UpdateThe New England Journal of Medicine, 1986
- Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor sepharose chromatographyBiochemical Pharmacology, 1984